Transcribed-Ultra Conserved Region expression is associated with outcome in high-risk neuroblastoma - PubMed (original) (raw)
Transcribed-Ultra Conserved Region expression is associated with outcome in high-risk neuroblastoma
Paola Scaruffi et al. BMC Cancer. 2009.
Abstract
Background: Neuroblastoma is the most common, pediatric, extra-cranial, malignant solid tumor. Despite multimodal therapeutic protocols, outcome for children with a high-risk clinical phenotype remains poor, with long-term survival still less than 40%. Hereby, we evaluated the potential of non-coding RNA expression to predict outcome in high-risk, stage 4 neuroblastoma.
Methods: We analyzed expression of 481 Ultra Conserved Regions (UCRs) by reverse transcription-quantitative real-time PCR and of 723 microRNAs by microarrays in 34 high-risk, stage 4 neuroblastoma patients.
Results: First, the comparison of 8 short- versus 12 long-term survivors showed that 54 UCRs were significantly (P < 0.0491) over-expressed in the former group. For 48 Ultra Conserved Region (UCRs) the expression levels above the cut-off values defined by ROC curves were strongly associated with good-outcome (OS: 0.0001 <P < 0.0185, EFS: 0.0001 <P < 0.0491). Then we tested the Transcribed-UCR (T-UCR) threshold risk-prediction model on an independent cohort of 14 patients. The expression profile of 28 T-UCRs was significantly associated to prognosis and at least 15 up-regulated T-UCRs are needed to discriminate (P < 0.0001) short- from long-survivors at the highest sensitivity and specificity (94.12%). We also identified a signature of 13 microRNAs differently expressed between long- and short-surviving patients. The comparative analysis of the two classes of non-coding RNAs disclosed that 9 T-UCRs display their expression level that are inversely correlated with expression of 5 complementary microRNAs of the signature, indicating a negative regulation of T-UCRs by direct interaction with microRNAs. Moreover, 4 microRNAs down-regulated in tumors of long-survivors target 3 genes implicated in neuronal differentiation, that are known to be over-expressed in low-risk tumors.
Conclusions: Our pilot study suggests that a deregulation of the microRNA/T-UCR network may play an important role in the pathogenesis of neuroblastoma. After further validation on a larger independent set of samples, such findings may be applied as the first T-UCR prognostic signature for high-risk neuroblastoma patients.
Figures
Figure 1
(A) ROC curve. Sensitivity and specificity in predicting survival based on different numbers of T-UCRs whose expression levels are above the thresholds defined by each respective ROC curve. The point marked with the red dot represents the highest average of sensitivity and specificity at the cut-off value of 15 (AUC = 0.988, Z statistic = 25.078, P = 0.0001). Kaplan-Meier analysis for (B) overall and (C) event-free survival of all 34 NBs. Comparison of survival probabilities of patients with ≥15 or <15 up-regulated T-UCRs. In each graph are reported the number of patients in predicted subgroups and the number of patients with event (between brackets).
Figure 2
Hierarchically clustered heat map of differentially expressed microRNAs (n = 13) between the two tumors conditions. Non-detected signals are indicated in white. On top bar, short-survivors tumors (yellow) and long-survivor tumors (blue) are shown.
Similar articles
- Expressional alterations in functional ultra-conserved non-coding RNAs in response to all-trans retinoic acid--induced differentiation in neuroblastoma cells.
Watters KM, Bryan K, Foley NH, Meehan M, Stallings RL. Watters KM, et al. BMC Cancer. 2013 Apr 8;13:184. doi: 10.1186/1471-2407-13-184. BMC Cancer. 2013. PMID: 23565812 Free PMC article. - An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours.
Mestdagh P, Fredlund E, Pattyn F, Rihani A, Van Maerken T, Vermeulen J, Kumps C, Menten B, De Preter K, Schramm A, Schulte J, Noguera R, Schleiermacher G, Janoueix-Lerosey I, Laureys G, Powel R, Nittner D, Marine JC, Ringnér M, Speleman F, Vandesompele J. Mestdagh P, et al. Oncogene. 2010 Jun 17;29(24):3583-92. doi: 10.1038/onc.2010.106. Epub 2010 Apr 12. Oncogene. 2010. PMID: 20383195 - Non-coding RNAs transcribed from ultra-conserved regions (T-UCRs) are differentially expressed in dental follicle tissues of impacted mandibular third molars.
Bozgeyik I, Ege B, Koparal M, Yumrutas O. Bozgeyik I, et al. J Stomatol Oral Maxillofac Surg. 2022 Jun;123(3):271-275. doi: 10.1016/j.jormas.2022.04.015. Epub 2022 Apr 25. J Stomatol Oral Maxillofac Surg. 2022. PMID: 35477012 - The dark matter of the human genome and its role in human cancers.
Bozgeyik I. Bozgeyik I. Gene. 2022 Feb 15;811:146084. doi: 10.1016/j.gene.2021.146084. Epub 2021 Nov 26. Gene. 2022. PMID: 34843880 Review. - The Transcribed-Ultra Conserved Regions: Novel Non-Coding RNA Players in Neuroblastoma Progression.
Mudgapalli N, Shaw BP, Chava S, Challagundla KB. Mudgapalli N, et al. Noncoding RNA. 2019 Jun 4;5(2):39. doi: 10.3390/ncrna5020039. Noncoding RNA. 2019. PMID: 31167408 Free PMC article. Review.
Cited by
- Implication of lncRNA MSTRG.81401 in Hippocampal Pyroptosis Induced by P2X7 Receptor in Type 2 Diabetic Rats with Neuropathic Pain Combined with Depression.
Zhan T, Tang S, Du J, Liu J, Yu B, Yang Y, Xie Y, Qiu Y, Li G, Gao Y. Zhan T, et al. Int J Mol Sci. 2024 Jan 18;25(2):1186. doi: 10.3390/ijms25021186. Int J Mol Sci. 2024. PMID: 38256257 Free PMC article. - Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN.
Fuchs S, Danßmann C, Klironomos F, Winkler A, Fallmann J, Kruetzfeldt LM, Szymansky A, Naderi J, Bernhart SH, Grunewald L, Helmsauer K, Rodriguez-Fos E, Kirchner M, Mertins P, Astrahantseff K, Suenkel C, Toedling J, Meggetto F, Remke M, Stadler PF, Hundsdoerfer P, Deubzer HE, Künkele A, Lang P, Fuchs J, Henssen AG, Eggert A, Rajewsky N, Hertwig F, Schulte JH. Fuchs S, et al. Nat Commun. 2023 Jul 4;14(1):3936. doi: 10.1038/s41467-023-38747-4. Nat Commun. 2023. PMID: 37402719 Free PMC article. - Transcribed Ultraconserved Regions: New regulators in cancer signaling and potential biomarkers.
Oliveira JC. Oliveira JC. Genet Mol Biol. 2023 Jan 9;46(1 Suppl 2):e20220125. doi: 10.1590/1678-4685-GMB-2022-0125. eCollection 2023. Genet Mol Biol. 2023. PMID: 36622962 Free PMC article. - UC.183, UC.110, and UC.84 Ultra-Conserved RNAs Are Mutually Exclusive with miR-221 and Are Engaged in the Cell Cycle Circuitry in Breast Cancer Cell Lines.
Corrà F, Crudele F, Baldassari F, Bianchi N, Galasso M, Minotti L, Agnoletto C, Di Leva G, Brugnoli F, Reali E, Bertagnolo V, Vecchione A, Volinia S. Corrà F, et al. Genes (Basel). 2021 Dec 13;12(12):1978. doi: 10.3390/genes12121978. Genes (Basel). 2021. PMID: 34946928 Free PMC article. - The transcribed ultraconserved region uc.160+ enhances processing and A-to-I editing of the miR-376 cluster: hypermethylation improves glioma prognosis.
Soler M, Davalos V, Sánchez-Castillo A, Mora-Martinez C, Setién F, Siqueira E, Castro de Moura M, Esteller M, Guil S. Soler M, et al. Mol Oncol. 2022 Feb;16(3):648-664. doi: 10.1002/1878-0261.13121. Epub 2021 Nov 3. Mol Oncol. 2022. PMID: 34665919 Free PMC article.
References
- London WB, Castleberry RP, Matthay KK, Look AT, Seeger RC, Shimada H, Thorner P, Brodeur G, Maris JM, Reynolds CP, Cohn SL. Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group. J Clin Oncol. 2005;23:6459–6465. doi: 10.1200/JCO.2005.05.571. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical